INGRAM ROBERT ALEXANDER 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Mar 2, 2022
Insider Transaction Report
Form 4
INGRAM ROBERT ALEXANDER
Director
Transactions
- Award
Common Stock
2022-02-28$16.61/sh+1,128$18,736→ 80,060 total
Footnotes (1)
- [F1]Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $18,750.